Skip to main content
All lobbying filings

The Metrohealth System

The Metrohealth System filed a Q1 report for The Metrohealth System on April 20, 2026.

Lobbying for The Metrohealth System

As filed: THE METROHEALTH SYSTEM for THE METROHEALTH SYSTEM.

All filings by The Metrohealth System · Everything The Metrohealth System has reported

 Filing · LD-2 quarterly report Q1 report
Reporting period
1st Quarter 2026
Jan 1 - Mar 31 · Posted Apr 20, 2026
Expenses
$190,000
What this organization spent lobbying with its own staff. Reported using the LDA's own definitions (method A): the three LDA methods count different costs, so an expenses figure is not comparable across filers that used different ones.
Client based in
Ohio

Official filing document

 Government bodies contacted 4

The chambers, agencies and offices the filer named. It does not say who inside them was contacted, or when. Each name opens every filing that named the same body.

 Lobbying activity 5
Medicare/Medicaid

Medicaid State Directed Payments; 340B modernization; funding for Disproportionate Share Hospitals (Medicaid DSH); funding for Medicare graduate medical education (GME); Medicare site neutrality policies; support of telehealth policies; impact of regional oversaturation of trauma care on patient outcomes and health system costs; H.R. 4313/S. 2237, Hospital Inpatient Services Modernization Act; H.R. 267, the Health Care Price Transparency Act; H.R. 2590/S. 1264, the Mental and Physical Health Care Comorbidities Act of 2025.

Health Issues

Sustainability of safety net health systems; social determinants of health; promoting coordinated care; support of telehealth policies; 340B modernization; impact of regional oversaturation of trauma care on patient outcomes and health system costs; Pandemic and All Hazards Preparedness Act reauthorization; H.R. 267, the Health care PRICE Transparency Act; H.R. 5256, the 340B ACCESS Act; H.R. 4392, Uterine Fibroid Intervention and Gynecological Health Treatment Act of 2025.

Budget/Appropriations

Funding for drug therapeutic infusion pumps; H.R. 5371, the Continuing Appropriations and Extensions Act, 2026.

Pharmacy

H.R. 5256, the 340B ACCESS Act.

Defense

FY 2027 National Defense Authorization Act.

 Bills named in this filing 8
  • H.R. 4313
    Hospital Inpatient Services Modernization Act
  • S. 2237
    Hospital Inpatient Services Modernization Act
  • H.R. 267
    Health Care PRICE Transparency Act
  • H.R. 2590
    Mental and Physical Health Care Comorbidities Act of 2025
  • S. 1264
    Mental and Physical Health Care Comorbidities Act of 2025
  • H.R. 5256
    340B ACCESS Act
  • H.R. 4392
    Uterine Fibroid Intervention and Gynecological Health Treatment Act of 2025
  • H.R. 5371
    Continuing Appropriations, Agriculture, Legislative Branch, Military Construction and Veterans Affairs, and Extensions …

Source: federal Lobbying Disclosure Act filing, reproduced as filed. Bills are parsed from the activity descriptions.

Report a problem